ジェネリック医薬品市場世界の産業動向、シェア、サイズ、成長、機会、2023-2028年予測Generic Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 世界のジェネリック医薬品市場規模は、2022年に3,436億米ドルに達しました。今後、IMARC Groupは、2023年から2028年の間に6.83%の成長率(CAGR)を示し、2028年までに4605億米ドルに達すると予測しています。 ... もっと見る
サマリー世界のジェネリック医薬品市場規模は、2022年に3,436億米ドルに達しました。今後、IMARC Groupは、2023年から2028年の間に6.83%の成長率(CAGR)を示し、2028年までに4605億米ドルに達すると予測しています。ジェネリック医薬品は、先発医薬品と生物学的に同等であり、同じ有効成分で同等の治療効果があります。また、用量、危険性、結果、副作用、強度、使用目的、投与経路も同様である。これらの医薬品は、製造に大規模な研究を必要としないため、先発医薬品よりも比較的安価です。さらに、ジェネリック医薬品の製造には、薬の有効性と安全性を測定するための臨床試験や動物実験を繰り返す必要がありません。その結果、ジェネリック医薬品は世界中で絶大な支持を集めています。 ジェネリック医薬品の市場動向: 高齢者人口の増加や、がん、糖尿病、心血管疾患などの慢性疾患の増加が、市場にプラスの影響を与える主な要因の一つとなっています。また、食生活の変化や多忙なスケジュールが様々な症状を引き起こし、それがジェネリック医薬品の世界的な需要を喚起しています。また、医療費削減やジェネリック医薬品の製造・普及を促進するための各国政府の取り組みが活発化していることも、市場の成長に寄与しています。また、効果的なジェネリック医薬品を導入し、簡単に入手できるようにすることが、主要企業の後押しとなっています。これとは別に、ジェネリック医薬品の製造コストが低いことも、市場に明るい展望をもたらしています。さらに、製薬会社や医療機関の世界的な拡大が、市場の成長をさらに後押ししています。さらに、大手メーカーが新製品を発売するためのパートナーシップ戦略に注力するようになったことが、市場の成長を後押ししています。さらに、大規模な研究開発(R&D)活動への投資の増加や医薬品の処方における技術の進歩が、市場を牽引すると予想されます。 主要な市場セグメント: IMARC Groupは、世界のジェネリック医薬品市場レポートの各サブセグメントにおける主要トレンドの分析と、2023年から2028年までの世界および国レベルでの予測を提供しています。当レポートでは、市場を治療領域、ドラッグデリバリー、流通チャネルに基づき分類しています。 治療領域別の内訳: 中枢神経系 心血管系 皮膚科学 泌尿器・ホルモン 呼吸器 リウマチ科 糖尿病 オンコロジー その他 中枢神経系(CNS)は、世界中で脳や脊髄の病気が増加していることから、主要な治療分野となっています。 ドラッグデリバリーによるブレークアップ: オーラル インジェクタブル 経皮・外用 吸入器 経口薬は、その便利な投与方法から、最も好まれる薬物送達形態であり、最小限の医療支援を必要とするものです。 流通チャネル別構成比: 小売薬局 病院内薬局 現在、ジェネリック医薬品の多くは一般用医薬品であり、処方箋を必要としないことから、小売薬局の店舗で流通しています。 国別構成比: ユーエスエー 中国 ブラジル ドイツ フランス インド イギリス 日本 カナダ イタリア その他 米国は、ジェネリック医薬品の製造とアクセスを改善するために、政府当局が実施した多くの取り組みにより、市場で明確な優位性を示しています。 競合の状況: 市場は大小さまざまなメーカーが存在するため、その性質上、断片化されている。市場で活動している主要なプレーヤーには、Teva Pharmaceuticals Industries Ltd., Mylan N.V., Novartis AG, Pfizer Inc., Sun Pharmaceutical Industries Ltd., Fresenius SE & Co., Lupin Limited, Endo Pharmaceuticals Inc., Aurobindo Pharma Limited, and Aspen Pharmacare Holdings Limitedなどがあります。 本レポートで回答した主な質問 1.2022年のジェネリック医薬品の世界市場規模は? 2.2023年~2028年のジェネリック医薬品の世界市場の予想成長率は? 3.世界のジェネリック医薬品市場を牽引する主要因は何か? 4.COVID-19が世界のジェネリック医薬品市場に与えた影響とは? 5.ジェネリック医薬品の世界市場における治療分野別の内訳は? 6.ジェネリック医薬品の世界市場において、ドラッグデリバリーに基づく内訳は? 7.ジェネリック医薬品の世界市場の流通チャネル別の内訳はどうなっていますか? 8.世界のジェネリック医薬品市場の主要地域は? 9.世界のジェネリック医薬品市場における主要プレイヤー/企業は? 目次1 Preface2 Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends 5 Global Generic Drugs Industry 5.1 Market Overview 5.2 Market Performance 5.3 Impact of COVID-19 5.4 Market Breakup by Country 5.5 Market Breakup by Therapy Area 5.6 Market Breakup by Drug Delivery 5.7 Market Breakup by Distribution Channel 5.8 Market Forecast 5.9 SWOT Analysis 5.9.1 Overview 5.9.2 Strengths 5.9.3 Weaknesses 5.9.4 Opportunities 5.9.5 Threats 5.10 Value Chain Analysis 5.10.1 Research and Development 5.10.2 Manufacturing 5.10.3 Marketing and Distribution 5.11 Porter’s Five Forces Analysis 5.11.1 Overview 5.11.2 Bargaining Power of Buyers 5.11.3 Bargaining Power of Suppliers 5.11.4 Degree of Competition 5.11.5 Threat of New Entrants 5.11.6 Threat of Substitutes 5.12 Regulations in the Generic Industry 5.13 Key Market Drivers and Success Factors 6 Performance of Key Countries 6.1 United States 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 China 6.2.1 Market Trends 6.2.2 Market Forecast 6.3 Brazil 6.3.1 Market Trends 6.3.2 Market Forecast 6.4 Germany 6.4.1 Market Trends 6.4.2 Market Forecast 6.5 France 6.5.1 Market Trends 6.5.2 Market Forecast 6.6 India 6.6.1 Market Trends 6.6.2 Market Forecast 6.7 United Kingdom 6.7.1 Market Trends 6.7.2 Market Forecast 6.8 Japan 6.8.1 Market Trends 6.8.2 Market Forecast 6.9 Canada 6.9.1 Market Trends 6.9.2 Market Forecast 6.10 Italy 6.10.1 Market Trends 6.10.2 Market Forecast 6.11 Others 6.11.1 Market Trends 6.11.2 Market Forecast 7 Market Breakup by Therapy Area 7.1 Central Nervous System 7.1.1 Market Trends 7.1.2 Market Forecast 7.2 Cardiovascular 7.2.1 Market Trends 7.2.2 Market Forecast 7.3 Dermatology 7.3.1 Market Trends 7.3.2 Market Forecast 7.4 Genitourinary/Hormonal 7.4.1 Market Trends 7.4.2 Market Forecast 7.5 Respiratory 7.5.1 Market Trends 7.5.2 Market Forecast 7.6 Rheumatology 7.6.1 Market Trends 7.6.2 Market Forecast 7.7 Diabetes 7.7.1 Market Trends 7.7.2 Market Forecast 7.8 Oncology 7.8.1 Market Trends 7.8.2 Market Forecast 7.9 Others 7.9.1 Market Trends 7.9.2 Market Forecast 8 Market Breakup by Drug Delivery 8.1 Oral 8.1.1 Market Trends 8.1.2 Market Forecast 8.2 Injectables 8.2.1 Market Trends 8.2.2 Market Forecast 8.3 Dermal/Topical 8.3.1 Market Trends 8.3.2 Market Forecast 8.4 Inhalers 8.4.1 Market Trends 8.4.2 Market Forecast 9 Market Breakup by Distribution Channel 9.1 Retail Pharmacies 9.1.1 Market Trends 9.1.2 Market Forecast 9.2 Hospital Pharmacies 9.2.1 Market Trends 9.2.2 Market Forecast 10 Competitive Landscape 10.1 Market Structure 10.2 Market Breakup by Key Players 10.3 Key Player Profiles 10.3.1 Teva Pharmaceuticals Industries Ltd. 10.3.2 Mylan N.V. 10.3.3 Novartis AG 10.3.4 Pfizer Inc. 10.3.5 Sun Pharmaceutical Industries Ltd. 10.3.6 Fresenius SE & Co. 10.3.7 Lupin Limited 10.3.8 Endo Pharmaceuticals Inc. 10.3.9 Aurobindo Pharma Limited 10.3.10 Aspen Pharmacare Holdings Limited 11 Generic Drugs Manufacturing Process 11.1 Product Overview 11.2 Detailed Process Flow (Tablets) 11.3 Detailed Process Flow (Injectable) 11.4 Various Types of Unit Operations Involved 11.5 Mass Balance and Raw Material Requirements 12 Project Details, Requirements and Costs Involved 12.1 Land Requirements and Expenditures 12.2 Construction Requirements and Expenditures 12.3 Plant Machinery 12.4 Machinery Pictures 12.5 Raw Material Requirements and Expenditures 12.6 Packaging Requirements and Expenditures 12.7 Transportation Requirements and Expenditures 12.8 Utility Requirements and Expenditures 12.9 Manpower Requirements and Expenditures 12.10 Other Capital Investments 13 Loans and Financial Assistance 14 Project Economics 14.1 Capital Cost of the Project 14.2 Techno-Economic Parameters 14.3 Product Pricing and Margins Across Various Levels of the Supply Chain 14.4 Taxation and Depreciation 14.5 Income Projections 14.6 Expenditure Projections 14.7 Financial Analysis 14.8 Profit Analysis List of Figure Figure 1: Global: Generic Drugs Market: Major Drivers and Challenges Figure 2: Global: Generic Drugs Market: Sales Value (in Billion US$), 2017-2022 Figure 3: Global: Generic Drugs Market Forecast: Sales Value (in Billion US$), 2023-2028 Figure 4: Global: Generic Drugs Market: Breakup by Country (in %), 2022 Figure 5: Global: Generic Drugs Market: Breakup by Therapy Area (in %), 2022 Figure 6: Global: Generic Drugs Market: Breakup by Drug Delivery (in %), 2022 Figure 7: Global: Generic Drugs Market: Breakup by Distribution Channel (in %), 2022 Figure 8: Global: Generic Drugs Industry: SWOT Analysis Figure 9: Global: Generic Drugs Industry: Value Chain Analysis Figure 10: Global: Generic Drugs Industry: Porter’s Five Forces Analysis Figure 11: USA: Generic Drugs Market (in Million US$), 2017 & 2022 Figure 12: USA: Generic Drugs Market Forecast (in Million US$), 2023-2028 Figure 13: China: Generic Drugs Market (in Million US$), 2017 & 2022 Figure 14: China: Generic Drugs Market Forecast (in Million US$), 2023-2028 Figure 15: Brazil: Generic Drugs Market (in Million US$), 2017 & 2022 Figure 16: Brazil: Generic Drugs Market Forecast (in Million US$), 2023-2028 Figure 17: Germany: Generic Drugs Market (in Million US$), 2017 & 2022 Figure 18: Germany: Generic Drugs Market Forecast (in Million US$), 2023-2028 Figure 19: France: Generic Drugs Market (in Million US$), 2017 & 2022 Figure 20: France: Generic Drugs Market Forecast (in Million US$), 2023-2028 Figure 21: India: Generic Drugs Market (in Million US$), 2017 & 2022 Figure 22: India: Generic Drugs Market Forecast (in Million US$), 2023-2028 Figure 23: United Kingdom: Generic Drugs Market (in Million US$), 2017 & 2022 Figure 24: United Kingdom: Generic Drugs Market Forecast (in Million US$), 2023-2028 Figure 25: Japan: Generic Drugs Market (in Million US$), 2017 & 2022 Figure 26: Japan: Generic Drugs Market Forecast (in Million US$), 2023-2028 Figure 27: Canada: Generic Drugs Market (in Million US$), 2017 & 2022 Figure 28: Canada: Generic Drugs Market Forecast (in Million US$), 2023-2028 Figure 29: Italy: Generic Drugs Market (in Million US$), 2017 & 2022 Figure 30: Italy: Generic Drugs Market Forecast (in Million US$), 2023-2028 Figure 31: Others: Generic Drugs Market (in Million US$), 2017 & 2022 Figure 32: Others: Generic Drugs Market Forecast (in Million US$), 2023-2028 Figure 33: Global: Generic Drugs Market: Oral (in Million US$), 2017 & 2022 Figure 34: Global: Generic Drugs Market Forecast: Oral (in Million US$), 2023-2028 Figure 35: Global: Generic Drugs Market: Injectables (in Million US$), 2017 & 2022 Figure 36: Global: Generic Drugs Market Forecast: Injectables (in Million US$), 2023-2028 Figure 37: Global: Generic Drugs Market: Dermal/Topical (in Million US$), 2017 & 2022 Figure 38: Global: Generic Drugs Market Forecast: Dermal/Topical (in Million US$), 2023-2028 Figure 39: Global: Generic Drugs Market: Inhalers (in Million US$), 2017 & 2022 Figure 40: Global: Generic Drugs Market Forecast: Inhalers (in Million US$), 2023-2028 Figure 41: Global: Generic Drugs Market: Central Nervous System (in Million US$), 2017 & 2022 Figure 42: Global: Generic Drugs Market Forecast: Central Nervous System (in Million US$), 2023-2028 Figure 43: Global: Generic Drugs Market: Cardiovascular (in Million US$), 2017 & 2022 Figure 44: Global: Generic Drugs Market Forecast: Cardiovascular (in Million US$), 2023-2028 Figure 45: Global: Generic Drugs Market: Dermatology (in Million US$), 2017 & 2022 Figure 46: Global: Generic Drugs Market Forecast: Dermatology (in Million US$), 2023-2028 Figure 47: Global: Generic Drugs Market: Genitourinary/Hormonal (in Million US$), 2017 & 2022 Figure 48: Global: Generic Drugs Market Forecast: Genitourinary/Hormonal (in Million US$), 2023-2028 Figure 49: Global: Generic Drugs Market: Respiratory (in Million US$), 2017 & 2022 Figure 50: Global: Generic Drugs Market Forecast: Respiratory (in Million US$), 2023-2028 Figure 51: Global: Generic Drugs Market: Rheumatology (in Million US$), 2017 & 2022 Figure 52: Global: Generic Drugs Market Forecast: Rheumatology (in Million US$), 2023-2028 Figure 53: Global: Generic Drugs Market: Diabetes (in Million US$), 2017 & 2022 Figure 54: Global: Generic Drugs Market Forecast: Diabetes (in Million US$), 2023-2028 Figure 55: Global: Generic Drugs Market: Oncology (in Million US$), 2017 & 2022 Figure 56: Global: Generic Drugs Market Forecast: Oncology (in Million US$), 2023-2028 Figure 57: Global: Generic Drugs Market: Other Therapy Areas (in Million US$), 2017 & 2022 Figure 58: Global: Generic Drugs Market Forecast: Other Therapy Areas (in Million US$), 2023-2028 Figure 59: Global: Generic Drugs Market: Retail Pharmacies (in Million US$), 2017 & 2022 Figure 60: Global: Generic Drugs Market Forecast: Retail Pharmacies (in Million US$), 2023-2028 Figure 61: Global: Generic Drugs Market: Hospital Pharmacies (in Million US$), 2017 & 2022 Figure 62: Global: Generic Drugs Market Forecast: Hospital Pharmacies (in Million US$), 2023-2028 Figure 63: Generic Drugs Industry: Profit Margins at Various Levels of the Supply Chain Figure 64: Generic Drugs Manufacturing: Production Cost Breakup (in %) Figure 65: Generic Drugs Manufacturing: Detailed Process Flow Figure 66: Generic Drugs Manufacturing Process: Conversion Rate of Feedstocks Figure 67: Generic Drugs Manufacturing: Proposed Plant Layout Figure 68: Generic Drugs Manufacturing Plant: Breakup of Capital Costs (in %) List of Table Table 1: Global: Generic Drugs Market: Key Industry Highlights, 2022 and 2028 Table 2: Global: Generic Drugs Market Forecast: Breakup by Country (in Million US$), 2023-2028 Table 3: Global: Generic Drugs Market Forecast: Breakup by Therapy Area (in Million US$), 2023-2028 Table 4: Global: Generic Drugs Market Forecast: Breakup by Drug Delivery (in Million US$), 2023-2028 Table 5: Global: Generic Drugs Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028 Table 6: Generic Drugs Market: Competitive Structure Table 7: Generic Drugs Market: Key Players Table 8: Generic Drugs Manufacturing Plant: Costs Related to Land and Site Development (in US$) Table 9: Generic Drugs Manufacturing Plant: Costs Related to Civil Works (in US$) Table 10: Generic Drugs Manufacturing Plant: Costs Related to Machinery Unit (in US$) Table 11: Generic Drugs Manufacturing Plant: Raw Material Requirements Table 12: Generic Drugs Manufacturing Plant: Costs Related to Salaries and Wages (in US$) Table 13: Generic Drugs Manufacturing Plant: Costs Related to Other Capital Investments (in US$) Table 14: Details of Financial Assistance Offered by Financial Institutions Table 15: Generic Drugs Manufacturing Plant: Capital Costs (in US$) Table 16: Generic Drugs Manufacturing Plant: Techno-Economic Parameters Table 17: Generic Drugs Manufacturing Plant: Taxation and Depreciation (in US$) Table 18: Generic Drugs Manufacturing Plant: Income Projections (in US$) Table 19: Generic Drugs Manufacturing Plant: Expenditure Projections (in US$) Table 20: Generic Drugs Manufacturing Plant: Cash Flow Analysis Without Considering the Income Tax Liability (in US$) Table 21: Generic Drugs Manufacturing Plant: Cash Flow Analysis on Considering the Income Tax Liability (in US$) Table 22: Generic Drugs Manufacturing Plant: Profit and Loss Account (in US$)
SummaryThe global generic drugs market size reached US$ 343.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 460.5 Billion by 2028, exhibiting a growth rate (CAGR) of 6.83% during 2023-2028. Table of Contents1 Preface2 Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends 5 Global Generic Drugs Industry 5.1 Market Overview 5.2 Market Performance 5.3 Impact of COVID-19 5.4 Market Breakup by Country 5.5 Market Breakup by Therapy Area 5.6 Market Breakup by Drug Delivery 5.7 Market Breakup by Distribution Channel 5.8 Market Forecast 5.9 SWOT Analysis 5.9.1 Overview 5.9.2 Strengths 5.9.3 Weaknesses 5.9.4 Opportunities 5.9.5 Threats 5.10 Value Chain Analysis 5.10.1 Research and Development 5.10.2 Manufacturing 5.10.3 Marketing and Distribution 5.11 Porter’s Five Forces Analysis 5.11.1 Overview 5.11.2 Bargaining Power of Buyers 5.11.3 Bargaining Power of Suppliers 5.11.4 Degree of Competition 5.11.5 Threat of New Entrants 5.11.6 Threat of Substitutes 5.12 Regulations in the Generic Industry 5.13 Key Market Drivers and Success Factors 6 Performance of Key Countries 6.1 United States 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 China 6.2.1 Market Trends 6.2.2 Market Forecast 6.3 Brazil 6.3.1 Market Trends 6.3.2 Market Forecast 6.4 Germany 6.4.1 Market Trends 6.4.2 Market Forecast 6.5 France 6.5.1 Market Trends 6.5.2 Market Forecast 6.6 India 6.6.1 Market Trends 6.6.2 Market Forecast 6.7 United Kingdom 6.7.1 Market Trends 6.7.2 Market Forecast 6.8 Japan 6.8.1 Market Trends 6.8.2 Market Forecast 6.9 Canada 6.9.1 Market Trends 6.9.2 Market Forecast 6.10 Italy 6.10.1 Market Trends 6.10.2 Market Forecast 6.11 Others 6.11.1 Market Trends 6.11.2 Market Forecast 7 Market Breakup by Therapy Area 7.1 Central Nervous System 7.1.1 Market Trends 7.1.2 Market Forecast 7.2 Cardiovascular 7.2.1 Market Trends 7.2.2 Market Forecast 7.3 Dermatology 7.3.1 Market Trends 7.3.2 Market Forecast 7.4 Genitourinary/Hormonal 7.4.1 Market Trends 7.4.2 Market Forecast 7.5 Respiratory 7.5.1 Market Trends 7.5.2 Market Forecast 7.6 Rheumatology 7.6.1 Market Trends 7.6.2 Market Forecast 7.7 Diabetes 7.7.1 Market Trends 7.7.2 Market Forecast 7.8 Oncology 7.8.1 Market Trends 7.8.2 Market Forecast 7.9 Others 7.9.1 Market Trends 7.9.2 Market Forecast 8 Market Breakup by Drug Delivery 8.1 Oral 8.1.1 Market Trends 8.1.2 Market Forecast 8.2 Injectables 8.2.1 Market Trends 8.2.2 Market Forecast 8.3 Dermal/Topical 8.3.1 Market Trends 8.3.2 Market Forecast 8.4 Inhalers 8.4.1 Market Trends 8.4.2 Market Forecast 9 Market Breakup by Distribution Channel 9.1 Retail Pharmacies 9.1.1 Market Trends 9.1.2 Market Forecast 9.2 Hospital Pharmacies 9.2.1 Market Trends 9.2.2 Market Forecast 10 Competitive Landscape 10.1 Market Structure 10.2 Market Breakup by Key Players 10.3 Key Player Profiles 10.3.1 Teva Pharmaceuticals Industries Ltd. 10.3.2 Mylan N.V. 10.3.3 Novartis AG 10.3.4 Pfizer Inc. 10.3.5 Sun Pharmaceutical Industries Ltd. 10.3.6 Fresenius SE & Co. 10.3.7 Lupin Limited 10.3.8 Endo Pharmaceuticals Inc. 10.3.9 Aurobindo Pharma Limited 10.3.10 Aspen Pharmacare Holdings Limited 11 Generic Drugs Manufacturing Process 11.1 Product Overview 11.2 Detailed Process Flow (Tablets) 11.3 Detailed Process Flow (Injectable) 11.4 Various Types of Unit Operations Involved 11.5 Mass Balance and Raw Material Requirements 12 Project Details, Requirements and Costs Involved 12.1 Land Requirements and Expenditures 12.2 Construction Requirements and Expenditures 12.3 Plant Machinery 12.4 Machinery Pictures 12.5 Raw Material Requirements and Expenditures 12.6 Packaging Requirements and Expenditures 12.7 Transportation Requirements and Expenditures 12.8 Utility Requirements and Expenditures 12.9 Manpower Requirements and Expenditures 12.10 Other Capital Investments 13 Loans and Financial Assistance 14 Project Economics 14.1 Capital Cost of the Project 14.2 Techno-Economic Parameters 14.3 Product Pricing and Margins Across Various Levels of the Supply Chain 14.4 Taxation and Depreciation 14.5 Income Projections 14.6 Expenditure Projections 14.7 Financial Analysis 14.8 Profit Analysis List of Figure Figure 1: Global: Generic Drugs Market: Major Drivers and Challenges Figure 2: Global: Generic Drugs Market: Sales Value (in Billion US$), 2017-2022 Figure 3: Global: Generic Drugs Market Forecast: Sales Value (in Billion US$), 2023-2028 Figure 4: Global: Generic Drugs Market: Breakup by Country (in %), 2022 Figure 5: Global: Generic Drugs Market: Breakup by Therapy Area (in %), 2022 Figure 6: Global: Generic Drugs Market: Breakup by Drug Delivery (in %), 2022 Figure 7: Global: Generic Drugs Market: Breakup by Distribution Channel (in %), 2022 Figure 8: Global: Generic Drugs Industry: SWOT Analysis Figure 9: Global: Generic Drugs Industry: Value Chain Analysis Figure 10: Global: Generic Drugs Industry: Porter’s Five Forces Analysis Figure 11: USA: Generic Drugs Market (in Million US$), 2017 & 2022 Figure 12: USA: Generic Drugs Market Forecast (in Million US$), 2023-2028 Figure 13: China: Generic Drugs Market (in Million US$), 2017 & 2022 Figure 14: China: Generic Drugs Market Forecast (in Million US$), 2023-2028 Figure 15: Brazil: Generic Drugs Market (in Million US$), 2017 & 2022 Figure 16: Brazil: Generic Drugs Market Forecast (in Million US$), 2023-2028 Figure 17: Germany: Generic Drugs Market (in Million US$), 2017 & 2022 Figure 18: Germany: Generic Drugs Market Forecast (in Million US$), 2023-2028 Figure 19: France: Generic Drugs Market (in Million US$), 2017 & 2022 Figure 20: France: Generic Drugs Market Forecast (in Million US$), 2023-2028 Figure 21: India: Generic Drugs Market (in Million US$), 2017 & 2022 Figure 22: India: Generic Drugs Market Forecast (in Million US$), 2023-2028 Figure 23: United Kingdom: Generic Drugs Market (in Million US$), 2017 & 2022 Figure 24: United Kingdom: Generic Drugs Market Forecast (in Million US$), 2023-2028 Figure 25: Japan: Generic Drugs Market (in Million US$), 2017 & 2022 Figure 26: Japan: Generic Drugs Market Forecast (in Million US$), 2023-2028 Figure 27: Canada: Generic Drugs Market (in Million US$), 2017 & 2022 Figure 28: Canada: Generic Drugs Market Forecast (in Million US$), 2023-2028 Figure 29: Italy: Generic Drugs Market (in Million US$), 2017 & 2022 Figure 30: Italy: Generic Drugs Market Forecast (in Million US$), 2023-2028 Figure 31: Others: Generic Drugs Market (in Million US$), 2017 & 2022 Figure 32: Others: Generic Drugs Market Forecast (in Million US$), 2023-2028 Figure 33: Global: Generic Drugs Market: Oral (in Million US$), 2017 & 2022 Figure 34: Global: Generic Drugs Market Forecast: Oral (in Million US$), 2023-2028 Figure 35: Global: Generic Drugs Market: Injectables (in Million US$), 2017 & 2022 Figure 36: Global: Generic Drugs Market Forecast: Injectables (in Million US$), 2023-2028 Figure 37: Global: Generic Drugs Market: Dermal/Topical (in Million US$), 2017 & 2022 Figure 38: Global: Generic Drugs Market Forecast: Dermal/Topical (in Million US$), 2023-2028 Figure 39: Global: Generic Drugs Market: Inhalers (in Million US$), 2017 & 2022 Figure 40: Global: Generic Drugs Market Forecast: Inhalers (in Million US$), 2023-2028 Figure 41: Global: Generic Drugs Market: Central Nervous System (in Million US$), 2017 & 2022 Figure 42: Global: Generic Drugs Market Forecast: Central Nervous System (in Million US$), 2023-2028 Figure 43: Global: Generic Drugs Market: Cardiovascular (in Million US$), 2017 & 2022 Figure 44: Global: Generic Drugs Market Forecast: Cardiovascular (in Million US$), 2023-2028 Figure 45: Global: Generic Drugs Market: Dermatology (in Million US$), 2017 & 2022 Figure 46: Global: Generic Drugs Market Forecast: Dermatology (in Million US$), 2023-2028 Figure 47: Global: Generic Drugs Market: Genitourinary/Hormonal (in Million US$), 2017 & 2022 Figure 48: Global: Generic Drugs Market Forecast: Genitourinary/Hormonal (in Million US$), 2023-2028 Figure 49: Global: Generic Drugs Market: Respiratory (in Million US$), 2017 & 2022 Figure 50: Global: Generic Drugs Market Forecast: Respiratory (in Million US$), 2023-2028 Figure 51: Global: Generic Drugs Market: Rheumatology (in Million US$), 2017 & 2022 Figure 52: Global: Generic Drugs Market Forecast: Rheumatology (in Million US$), 2023-2028 Figure 53: Global: Generic Drugs Market: Diabetes (in Million US$), 2017 & 2022 Figure 54: Global: Generic Drugs Market Forecast: Diabetes (in Million US$), 2023-2028 Figure 55: Global: Generic Drugs Market: Oncology (in Million US$), 2017 & 2022 Figure 56: Global: Generic Drugs Market Forecast: Oncology (in Million US$), 2023-2028 Figure 57: Global: Generic Drugs Market: Other Therapy Areas (in Million US$), 2017 & 2022 Figure 58: Global: Generic Drugs Market Forecast: Other Therapy Areas (in Million US$), 2023-2028 Figure 59: Global: Generic Drugs Market: Retail Pharmacies (in Million US$), 2017 & 2022 Figure 60: Global: Generic Drugs Market Forecast: Retail Pharmacies (in Million US$), 2023-2028 Figure 61: Global: Generic Drugs Market: Hospital Pharmacies (in Million US$), 2017 & 2022 Figure 62: Global: Generic Drugs Market Forecast: Hospital Pharmacies (in Million US$), 2023-2028 Figure 63: Generic Drugs Industry: Profit Margins at Various Levels of the Supply Chain Figure 64: Generic Drugs Manufacturing: Production Cost Breakup (in %) Figure 65: Generic Drugs Manufacturing: Detailed Process Flow Figure 66: Generic Drugs Manufacturing Process: Conversion Rate of Feedstocks Figure 67: Generic Drugs Manufacturing: Proposed Plant Layout Figure 68: Generic Drugs Manufacturing Plant: Breakup of Capital Costs (in %) List of Table Table 1: Global: Generic Drugs Market: Key Industry Highlights, 2022 and 2028 Table 2: Global: Generic Drugs Market Forecast: Breakup by Country (in Million US$), 2023-2028 Table 3: Global: Generic Drugs Market Forecast: Breakup by Therapy Area (in Million US$), 2023-2028 Table 4: Global: Generic Drugs Market Forecast: Breakup by Drug Delivery (in Million US$), 2023-2028 Table 5: Global: Generic Drugs Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028 Table 6: Generic Drugs Market: Competitive Structure Table 7: Generic Drugs Market: Key Players Table 8: Generic Drugs Manufacturing Plant: Costs Related to Land and Site Development (in US$) Table 9: Generic Drugs Manufacturing Plant: Costs Related to Civil Works (in US$) Table 10: Generic Drugs Manufacturing Plant: Costs Related to Machinery Unit (in US$) Table 11: Generic Drugs Manufacturing Plant: Raw Material Requirements Table 12: Generic Drugs Manufacturing Plant: Costs Related to Salaries and Wages (in US$) Table 13: Generic Drugs Manufacturing Plant: Costs Related to Other Capital Investments (in US$) Table 14: Details of Financial Assistance Offered by Financial Institutions Table 15: Generic Drugs Manufacturing Plant: Capital Costs (in US$) Table 16: Generic Drugs Manufacturing Plant: Techno-Economic Parameters Table 17: Generic Drugs Manufacturing Plant: Taxation and Depreciation (in US$) Table 18: Generic Drugs Manufacturing Plant: Income Projections (in US$) Table 19: Generic Drugs Manufacturing Plant: Expenditure Projections (in US$) Table 20: Generic Drugs Manufacturing Plant: Cash Flow Analysis Without Considering the Income Tax Liability (in US$) Table 21: Generic Drugs Manufacturing Plant: Cash Flow Analysis on Considering the Income Tax Liability (in US$) Table 22: Generic Drugs Manufacturing Plant: Profit and Loss Account (in US$)
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療)の最新刊レポート
IMARC Services Private Limited.社の医療分野での最新刊レポート
本レポートと同じKEY WORD(industry)の最新刊レポート
よくあるご質問IMARC Services Private Limited.社はどのような調査会社ですか?インドに調査拠点を持つ調査会社。幅広い分野をカバーしていますがケミカルに特に焦点を当てています。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/21 10:26 156.13 円 165.08 円 200.38 円 |